Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: SEZ6-targeting antibody-drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial.

Nature medicine·2026
Same author

Correction: Kim et al. Identification of <i>GREM-1</i> and <i>GAS6</i> as Specific Biomarkers for Cancer-Associated Fibroblasts Derived from Patients with Non-Small-Cell Lung Cancer. <i>Cancers</i> 2025, <i>17</i>, 2858.

Cancers·2026
Same author

Optimizing lymph node dissection for accurate nodal staging in early-stage esophageal squamous cell carcinoma: a multicenter study.

Esophagus : official journal of the Japan Esophageal Society·2026
Same author

SEZ6-targeting antibody-drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial.

Nature medicine·2026
Same author

Amivantamab in recurrent/metastatic HNSCC after checkpoint inhibitor and chemotherapy: pivotal results from the phase 1b/2 OrigAMI-4 study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Relationships between cognition and daily functioning in adults with bipolar disorder: A systematic review and multilevel meta-analysis.

Psychological bulletin·2026
Same journal

Development and Validation of Salivary Exosomal Tri-RNA Liquid Biopsy in Esophageal Carcinoma: A Multicenter Study.

JCO precision oncology·2026
Same journal

Implementing Timely Germline Genetic Testing for Patients With Pancreatic Cancer Using a Genetics Copilot for Point-of-Care Education and Health Assessment.

JCO precision oncology·2026
Same journal

Integrating DNA Mutations and RNA Expression of Cancer Driver Genes in Asian Rare Cancers: A Pan-Cancer Analysis.

JCO precision oncology·2026
Same journal

Sustained Response to Trametinib in Central Giant Cell Granuloma With <i>KRAS</i> Gain-of-Function Mutation: A Case Report.

JCO precision oncology·2026
Same journal

DNA Damage Response Alterations and Immune Checkpoint Blockade Outcomes Across Multiple Cancers.

JCO precision oncology·2026
Same journal

Prediction of Anthracycline Benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer by the MammaPrint 70-Gene Signature for Patients Enrolled in the FLEX Study.

JCO precision oncology·2026
See all related articles

Related Experiment Video

Updated: Jun 15, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

Deep-Learning Model for Real-Time Prediction of Recurrence in Early-Stage Non-Small Cell Lung Cancer: A Multimodal

Hyun Ae Jung1, Daehwan Lee2, Boram Park3,4

  • 1Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

JCO Precision Oncology
|July 23, 2025
PubMed
Summary
This summary is machine-generated.

A new deep-learning model predicts recurrence in early-stage non-small cell lung cancer (NSCLC) using routine clinical data. This RADAR score offers timely risk assessment to guide personalized surveillance and treatment strategies for NSCLC patients.

More Related Videos

Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer
07:53

Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer

Published on: October 13, 2023

1.6K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

199

Related Experiment Videos

Last Updated: Jun 15, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer
07:53

Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer

Published on: October 13, 2023

1.6K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

199

Area of Science:

  • Oncology
  • Artificial Intelligence
  • Medical Informatics

Background:

  • Current surveillance for early-stage non-small cell lung cancer (NSCLC) lacks personalization based on individual recurrence risk factors.
  • Longitudinal monitoring protocols are essential for timely detection of recurrence in NSCLC survivors.

Purpose of the Study:

  • To develop and validate a deep-learning model for predicting recurrence in early-stage NSCLC using comprehensive clinical data.
  • To create a practical tool for longitudinal monitoring that incorporates individualized risk assessment.

Main Methods:

  • A multimodal deep-learning model utilizing transformers was developed for real-time recurrence prediction.
  • The model integrated baseline clinical, pathological, and molecular data with longitudinal laboratory and radiologic surveillance data.
  • Data from 14,177 patients with stage I-III NSCLC treated with curative intent between 2008-2022 were analyzed.

Main Results:

  • The deep-learning model incorporated 64 distinct factors and demonstrated strong predictive performance.
  • The area under the curve (AUC) for predicting recurrence within one year was 0.854 across all stages.
  • The model achieved a sensitivity of 86.0% and specificity of 71.3%, with stage-specific AUCs ranging from 0.724 to 0.872.

Conclusions:

  • A deep-learning model using multimodal data from routine clinical practice can effectively predict relapse in early-stage NSCLC.
  • The developed RADAR risk score provides timely, actionable insights for clinicians.
  • This tool has the potential to guide risk-adapted surveillance and optimize adjuvant systemic treatment decisions for NSCLC patients.